Average Co-Inventor Count = 5.66
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Blueprint Medicines Corporation (19 from 60 patents)
2. Amgen Inc. (12 from 1,970 patents)
3. Merck Patent Gmbh (11 from 2,937 patents)
4. Other (1 from 832,680 patents)
43 patents:
1. 11827642 - Compositions useful for treating disorders related to KIT
2. 11634422 - Inhibitors of activin receptor-like kinase
3. 11236086 - Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
4. 11040979 - Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR
5. 10875837 - Inhibitors of the fibroblast growth factor receptor
6. 10413562 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
7. 10233186 - Inhibitors of activin receptor-like kinase
8. 10221154 - Inhibitors of the fibroblast growth factor receptor
9. 10016448 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
10. 10000496 - Compositions useful for treating disorders related to kit and PDGFR
11. 9994552 - Compositions useful for treating disorders related to kit
12. 9994575 - Compositions useful for treating disorders related to kit
13. 9944651 - Compositions useful for treating disorders related to kit
14. 9884861 - Compositions useful for treating disorders related to kit
15. 9708321 - Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4